Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women

American Journal of Clinical Nutrition

Volumn 64, Issue 2, 1996, Pages 131-136

  Uusitupa, Matti I J ^a   Karhunen, Leila ^b   Rissanen, Aila ^b   Franssila Kallunki, Anja ^b   Niskanen, Leo ^b   Kervinen, Kari ^b   Antero Kesaniemi Y ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NONE

Author keywords

apolipoprotein E phenotype; blood pressure; insulin; Lipids; obesity

Indexed keywords

APOLIPOPROTEIN E; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ALLELE; ARTICLE; BODY FAT; BODY MASS; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; OBESITY; PHENOTYPE;

EID: 0029954255     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/64.2.131     Document Type: Article

References (35)

1. Mahley RW. Apoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-40.
2. Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglyceride levels by apo E phenotype: a meta-analysis. J Lipid Res 1992;240:447-54.
3. Ehnholm C, Lukka M, Kuusi T, Nikkilä E, Uterman G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986;27:227-35.
4. Kesäniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency in man is related to apolipoprotein E phenotype. J Clin Invest 1987;80:578-81.
5. Davignon J, Gregg RE, Sing SF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
6. Kuusi T, Nieminen MS, Ehnholm C, et al. Apoprotein E polymorphism and coronary artery disease - increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis 1989;9:237-41.
7. Tiret L, de Knijff P, Menzel H-J, Ehnholm C, Nicaud V, Havekes LM. Apo E polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS study. European Atherosclerosis Research Study. Arterioscler Thromb 1994;14:1617-24.
8. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-A-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer's disease. Proc Natl Acad Sci U S A 1993;90:1977-81.
9. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-9.
10. Saunders AM, Schmader K, Breitner JCS, et al. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993;342:710-1.
11. Juvonen T, Kervinen K, Kairaluoma MI, Lajunen L, Kesäniemi YA. Gallstone cholesterol content is related to apolipoprotein E polymorphism. Gastroenterology 1993;104:1806-13.
12. Hjermann I, Helgeland A, Holme I, Lund-Larsen PG, Leren P. The association between blood pressure and serum cholesterol in healthy men: the Oslo study. J Epidemiol Community Health 1978;32:117-23.
13. Goode GK, Miller JP, Heagerty AM. Hyperlipidaemia, hypertension, and coronary heart disease. Lancet 1995;345:362-4.
14. Uusitupa M, Sarkkinen E, Kervinen K, Kesäniemi YA. Apolipoprotein E phenotype and blood pressure. Lancet 1994;343:57.
15. de Knijff P, Boomsma DI, Feskens EJM, et al. Apolipoprotein E phenotype and blood pressure. Lancet 1994;343:1234-5.
16. Björntorp P. The associations between obesity, adipose tissue distribution and disease. Acta Med Scand 1988;723:121-34.
17. Kissebah AH, Peins AN. Biology of regional body fat distribution. Diabetes Metab Rev 1989;5:83-109.
18. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
19. Despres J-P, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Genetic aspects of susceptibility to obesity and related dyslipidemias. Mol Cell Biochem 1992;113:151-69.
20. Laakso M, Sarlund H, Mykkänen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degree of glucose tolerance. Arteriosclerosis 1990;10:223-31.
21. Fumeron F, Rigaud D, Bertiere MC, Bardon S, Dely C, Appelbaum M. Association of apolipoprotein E 4 allele with hypertriglyceridaemia in obesity. Clin Genet 1988;34:258-64.
22. Gueguen R, Visvikis S, Steinmetz J, Siest G, Boerwinkle E. An analysis of genotype effects and their interactions by using apolipoprotein E polymorphism and, longitudinal data. Am J Hum Genet 1989;45:793-802.
23. Eto M, Watanabe K, Ishii K. Apolipoprotein E polymorphism and hyperlipidemia in obesity. Int J Obes 1989;13:433-40.
24. Pouliot M-C, Despres J-P, Moorjani S, Lupien PJ, Trembley A, Bouchard C. Apolipoprotein E polymorphism alters the association between body fatness and plasma lipoprotein in women. J Lipid Res 1990;31:1023-9.
25. Muls E, Kempen K, Vansant G, Cobbaert C, Saris W. The effects of weight loss and apolipoprotein E polymorphism on serum lipids, apolipoproteins A-I and B, and lipoprotein(a). Int J Obes 1993;17:711-6.
26. Despres J-P, Verdon M-F, Moorjani S, et al. Apolipoprotein E polymorphism modifies relation of hyperinsulinemia to hypertriglyceridemia. Diabetes 1993;42:1474-81.
27. Carmelli D, Cardon LR, Fabsitz R. Clustering of hypertension, diabetes, and obesity in adult male twins: same genes or same environments. Am J Hum Genet 1994;55:566-73.
28. Eggstein M. A new determination of the neutral fats in blood serum and tissue. II. Reliability of the method, other neutral fat determinations, normal values for triglycerides and glycerin in human blood. Klin Wochenschr 1966;44:267-73.
29. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977;23:882-4.
30. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983;29:1075-80.
31. Rindfrey H, Helger R, Lang H. Kinetic determination of glucose concentrations with glucose dehydrogenase. J Clin Chem Clin Biochem 1977;15:217-20.
32. Valdez R, Stern MP, Howard BV, Haffner SM. Apolipoprotein E polymorphism and insulin levels in a biethnic population. Diabetes Care 1995;18:993-1000.
33. Panza JA, Quyymi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
34. Henry PD. Hyperlipidemic arterial dysfunction. Circulation 1990;81:697-9.
35. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-7.